Ana Sayfa › Akciğer Kanseri › California › Los Angeles
Los Angeles, CA içinde Akciğer Kanseri klinik çalışmaları
Akciğer Kanseri için 45 çalışma, Los Angeles ve çevresindeki (yaklaşık 30 mil mesafedeki) merkezlerde katılımcı arıyor. Kimlerin katılabileceğini ve çalışma ekibine nasıl ulaşılacağını görmek için bir çalışmayı açın.
Resmi çalışma metni (İngilizce)
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
Katılımcı aranıyorEvre 1/2
- The Angeles Clinic and Research Institute (Melanoma), Los Angeles
- USC Norris Comprehensive Cancer Center (Melanoma/NSCLC), Los Angeles
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Katılımcı aranıyorEvre 3
- Kaiser Permanente Los Angeles Medical Center, Los Angeles
- Kaiser Permanente West Los Angeles, Los Angeles
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Katılımcı aranıyorEvre 1/2
- UCLA Jonsson Comprehensive Cancer Center, Los Angeles
- USC Norris Comprehensive Cancer Center, Los Angeles
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Katılımcı aranıyorEvre 3
- Cedars-Sinai Medical Center, Los Angeles
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Katılımcı aranıyorEvre 1
- University of California Los Angeles, Los Angeles
A Study of PHN-012 in Patients With Advanced Solid Tumors
Katılımcı aranıyorEvre 1
- PHN-012-001 Site, Los Angeles
A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]
Katılımcı aranıyorEvre 3
- GSK Investigational Site, Los Angeles
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Katılımcı aranıyorEvre 3
- UCLA Clinical & Translational Research Center (CTRC) ( Site 0033), Los Angeles
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Katılımcı aranıyorEvre 3
- Oncura Health - Good Samaritan, Los Angeles
- California Research Institute, Los Angeles
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Katılımcı aranıyorEvre 2
- Research Site, Los Angeles
A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors (EMBOLD PanTumour-103)
Katılımcı aranıyorEvre 1/2
- GSK Investigational Site, Los Angeles
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
Katılımcı aranıyorEvre 2/3
- USC/Norris Comprehensive Cancer Center, Los Angeles
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
Katılımcı aranıyorEvre 3
- Valkyrie Clinical Trials, Los Angeles
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Katılımcı aranıyorEvre 1/2
- The Angeles clinic - A cedars SINAI AFFILIATE, Los Angeles
- USC Norris Comprehensive Cancer Center, Los Angeles
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Katılımcı aranıyorEvre 1
- START - Los Angeles, Los Angeles
- Cedars Sinai, Los Angeles
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Katılımcı aranıyorEvre 3
- Cedars-Sinai Medical Center, Los Angeles
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Katılımcı aranıyorEvre 3
- UCLA Oncology Center, Los Angeles
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Katılımcı aranıyorEvre 1/2
- Avenzo Therapeutics Recruiting Site, Los Angeles
- Avenzo Therapeutics Recruiting Site, Los Angeles
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Katılımcı aranıyorEvre 3
- USC/Norris Comprehensive Cancer Center, Los Angeles
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Katılımcı aranıyorEvre 1
- University of Southern California, Los Angeles
- Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer, Los Angeles
- Cedars-Sanai Medical Center, Los Angeles
Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer
Katılımcı aranıyorEvre 1
- Cedars-Sinai Cancer at The Angeles Clinic and Research Institute, Los Angeles
- Cedars-Sinai Cancer at SOCC, Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Katılımcı aranıyorEvre 1
- UCLA - Hematology/Oncology Clinical Research Unit, Los Angeles
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Katılımcı aranıyorEvre 1/2
- California Research Institute, Los Angeles
- Valkyrie Clinical Trials, Los Angeles
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
Katılımcı aranıyorEvre 1/2
- USC Norris Comprehensive Cancer Center, Los Angeles
Mobile Application to Improve Health-Related Outcomes in Patients With Advanced Lung Cancer
Katılımcı aranıyor
- University of California Los Angeles, Los Angeles
- Veteran Affairs Greater Los Angeles Health Care, Los Angeles
EXoPERT EMERALD Clinical Study
Katılımcı aranıyorGözlemsel çalışmaSağlıklı gönüllüler kabul ediliyor
- City of Hope Duarte Cancer Center, Los Angeles
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Katılımcı aranıyorEvre 1
- Cedars-Sinai Medical Center, Los Angeles
Gilteritinib for the Treatment of ALK NSCLC
Katılımcı aranıyorEvre 1
- Cedars-Sinai Medical Center, Los Angeles
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
Katılımcı aranıyorEvre 1
- University of California, Los Angeles (UCLA) Department of Medicine - Hematology/Oncology, Los Angeles
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Katılımcı aranıyorEvre 1/2
- UCLA Medical Center, Los Angeles
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
Katılımcı aranıyorEvre 1/2
- The Angeles Clinic and Research Institute, Los Angeles
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Katılımcı aranıyorEvre 2
- Cedars-Sinai Medical Center, Los Angeles
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Katılımcı aranıyorEvre 2/3
- Kaiser Permanente Los Angeles Medical Center, Los Angeles
- Kaiser Permanente West Los Angeles, Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Katılımcı aranıyorEvre 2
- Cedars-Sinai Medical Center, Los Angeles
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Katılımcı aranıyor
- Oncology Institute for Hope and Innovation, Los Angeles
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Katılımcı aranıyorEvre 1/2
- Cedars-Sinai Medical Center, Los Angeles
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Katılımcı aranıyorEvre 1/2
- University of California Los Angeles, Los Angeles
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Katılımcı aranıyorEvre 1
- USC Norris Comprehensive Cancer Center, Los Angeles
Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma
Katılımcı aranıyorErken evre 1
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Katılımcı aranıyorEvre 1
- USC - Norris Comprehensive Cancer Center, Los Angeles
Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants
Katılımcı aranıyorSağlıklı gönüllüler kabul ediliyor
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Katılımcı aranıyorEvre 1/2
- Cedars Sinai Medical Center, Los Angeles
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Katılımcı aranıyorEvre 1/2
- UCLA Medical Center, Los Angeles
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
Katılımcı aranıyorGözlemsel çalışma
- Science 37, Los Angeles
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Katılımcı aranıyorEvre 2
- Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles
Diğer şehirlerde Akciğer Kanseri çalışmaları
- Houston, TX78 çalışma
- Boston, MA62 çalışma
- New York City, NY60 çalışma
- Arlington, VA41 çalışma
- Washington, DC41 çalışma
- Chicago, IL41 çalışma
- Baltimore, MD40 çalışma
- Nashville, TN40 çalışma
- St. Louis, MO39 çalışma
- Columbus, OH37 çalışma
- Philadelphia, PA36 çalışma
- Seattle, WA33 çalışma
Los Angeles içinde diğer çalışmalar
- Küçük Hücreli Olmayan Akciğer Kanseri87 çalışma
- Kanser (tüm türler)74 çalışma
- Meme Kanseri73 çalışma
- Prostat Kanseri61 çalışma
- Kolorektal Kanser59 çalışma
- Metastatik Kanser57 çalışma
- Yumurtalık Kanseri50 çalışma
- Baş ve Boyun Yassı Hücreli Karsinom42 çalışma
- Pankreas Kanseri35 çalışma
- Endometrium Kanseri34 çalışma
- Melanom34 çalışma
- Üçlü Negatif Meme Kanseri27 çalışma
ClinicalTrials.gov'dan alınmıştır, veri tarihi: 6 Eki 2026. Her çalışma kendi uygunluk kriterlerini belirler; katılım kararı çalışma ekibine aittir.